Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of rat nerve growth factor injection for optic nerve injury
ChiCTR-TRC-10000877Phase 2Completed
- Sponsor
- Beijing Tongren Hospital
- Start
- Apr 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of Nerve growth factor in Optic neuropathies (2 arms), sponsored by Beijing Tongren Hospital. Primary endpoints: Best corrected visual acuity and Effect score. Started Apr 2010; status: completed.
02
Drugs
Nerve growth factor
03
Conditions
Optic neuropathies
Beyond the preview
Go deeper on ChiCTR-TRC-10000877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000877.